Skip to main content
DongKook Life Science Co., Ltd. logo

DongKook Life Science Co., Ltd. — Investor Relations & Filings

Ticker · 303810 ISIN · KR7303810006 KO Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2025-08-19 Major Shareholding Noti…
Country KR South Korea
Listing KO 303810

About DongKook Life Science Co., Ltd.

http://www.dkls.co.kr/eng/

DongKook Life Science Co., Ltd. is a specialized pharmaceutical company focused on diagnostic medicine and medical devices. The company develops, manufactures, and supplies a range of products with a core specialization in contrast media for medical imaging modalities such as X-ray and magnetic resonance imaging (MRI). In addition to its diagnostic pharmaceuticals, the company is involved in developing AI-powered medical technology. With a strong emphasis on research and development, DongKook Life Science focuses on technical innovation and the creation of new products, having successfully localized key diagnostic medicines for the market. The company serves a global customer base across numerous countries.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. This type of filing is a standard regulatory requirement for insiders or major shareholders to disclose changes in their holdings. In the context of the provided categories, this falls under 'Director's Dealing' (DIRS), as it reports the share ownership changes of a major shareholder (DongKook Pharmaceutical) in the issuing company (DongKook Life Science).
2025-08-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a specific individual (Kim Ki-cheol) who is an executive at Dongkook Life Science. This type of filing is a standard regulatory requirement for insider trading or changes in shareholdings by company directors/executives, which corresponds to the 'Director's Dealing' category.
2025-08-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to report changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2025-08-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by company insiders (directors/executives). This falls under the 'Director's Dealing' category, as it reports personal share transactions or changes in ownership status by a company executive (Park Sang-hoon).
2025-08-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent filing) where company insiders report changes in their shareholdings. Since the document details the personal shareholding changes of an executive (Yang Hee-sung) due to a bonus issue, it falls under the category of Director's Dealing.
2025-08-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by insiders to report changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2025-08-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.